CoDiab-VD: protocol of a prospective population-based cohort study on diabetes care in Switzerland.
BACKGROUND
Diabetes represents an increasing health burden worldwide. In 2010, the Public Health Department of the canton of Vaud (Switzerland) launched a regional diabetes programme entitled "Programme cantonal Diabète" (PcD), with the objectives to both decrease the incidence of diabetes and improve care for patients with diabetes. The cohort entitled CoDiab-VD emerged from that programme. It specifically aimed at following quality of diabetes care over time, at evaluating the coverage of the PcD within this canton and at assessing the impact of the PcD on care of patients with diabetes.


METHODS
The cohort CoDiab-VD is a prospective population-based cohort study. Patients with diabetes were recruited in two waves (autumn 2011--summer 2012) through community pharmacies. Eligible participants were non-institutionalised adult patients (≥ 18 years) with diabetes diagnosed for at least one year, residing in the canton of Vaud and coming to a participating pharmacy with a diabetes-related prescription. Women with gestational diabetes, people with obvious cognitive impairment or insufficient command of French were not eligible. Self-reported data collected, included the following primary outcomes: processes-of-care indicators (annual checks) and outcomes of care such as HbA1C, (health-related) quality of life measures (Short Form-12 Health Survey--SF-12, Audit of Diabetes-Dependent Quality of Life 19--ADDQoL) and Patient Assessment of Chronic Illness Care (PACIC). Data on diabetes, health status, healthcare utilisation, health behaviour, self-management activities and support, knowledge of, or participation to, campaigns/activities proposed by the PcD, and socio-demographics were also obtained. For consenting participants, physicians provided few additional pieces of information about processes and laboratory results. Participants will be followed once a year, via a mailed self-report questionnaire. The core of the follow-up questionnaires will be similar to the baseline one, with the addition of thematic modules adapting to the development of the PcD. Physicians will be contacted every 2 years.


CONCLUSIONS
CoDiab-VD will allow obtaining a broad picture of the care of patients with diabetes, as well as their needs regarding their chronic condition. The data will be used to evaluate the PcD and help prioritise targeted actions.


BACKGROUND
This study is registered with ClinicalTrials.gov, identifier NCT01902043, July 9, 2013.
Institute of social and preventive medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland. Emilie.Zuercher@chuv.ch.
Emilie
E
Zuercher
Institute of social and preventive medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland. juliebordet@ymail.com.
Julie
J
Bordet
Institute of social and preventive medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland. Bernard.Burnand@chuv.ch.
Bernard
B
Burnand
Institute of social and preventive medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland. Isabelle.Peytremann-Bridevaux@chuv.ch.
Isabelle
I
Peytremann-Bridevaux
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002985:Clinical Protocols; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000517:prevention & control*; D005260:Female; D015438:Health Behavior; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011787:Quality of Health Care; D011788:Quality of Life; D012107:Research Design; D057566:Self Report; D013557:Switzerland